bempedoic acid
Selected indexed studies
- Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients. (N Engl J Med, 2023) [PMID:36876740]
- Bempedoic Acid. (, 2006) [PMID:33104321]
- Bempedoic Acid: for Whom and When. (Curr Atheroscler Rep, 2022) [PMID:35900636]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients. (2023) pubmed
- Bempedoic Acid. (2006) pubmed
- Bempedoic Acid: for Whom and When. (2022) pubmed
- Role of Bempedoic Acid in Clinical Practice. (2021) pubmed
- Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol. (2019) pubmed
- Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy. (2020) pubmed
- Bempedoic Acid: First Approval. (2020) pubmed
- Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease: The CLEAR Wisdom Randomized Clinical Trial. (2019) pubmed
- Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance. (2019) pubmed
- Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients. (2023) pubmed